JP2023529836A5 - - Google Patents

Info

Publication number
JP2023529836A5
JP2023529836A5 JP2022574455A JP2022574455A JP2023529836A5 JP 2023529836 A5 JP2023529836 A5 JP 2023529836A5 JP 2022574455 A JP2022574455 A JP 2022574455A JP 2022574455 A JP2022574455 A JP 2022574455A JP 2023529836 A5 JP2023529836 A5 JP 2023529836A5
Authority
JP
Japan
Prior art keywords
rsv
virus
sequence
composition
lid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022574455A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023529836A (ja
JP7888214B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/036030 external-priority patent/WO2021248086A2/en
Publication of JP2023529836A publication Critical patent/JP2023529836A/ja
Publication of JP2023529836A5 publication Critical patent/JP2023529836A5/ja
Application granted granted Critical
Publication of JP7888214B2 publication Critical patent/JP7888214B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022574455A 2020-06-05 2021-06-04 生弱毒化呼吸器合胞体ウイルス Active JP7888214B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063035617P 2020-06-05 2020-06-05
US63/035,617 2020-06-05
PCT/US2021/036030 WO2021248086A2 (en) 2020-06-05 2021-06-04 Live attenuated respiratory syncytial virus

Publications (3)

Publication Number Publication Date
JP2023529836A JP2023529836A (ja) 2023-07-12
JP2023529836A5 true JP2023529836A5 (cg-RX-API-DMAC7.html) 2024-06-11
JP7888214B2 JP7888214B2 (ja) 2026-07-13

Family

ID=76708442

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022574455A Active JP7888214B2 (ja) 2020-06-05 2021-06-04 生弱毒化呼吸器合胞体ウイルス

Country Status (10)

Country Link
US (1) US20230279362A1 (cg-RX-API-DMAC7.html)
EP (1) EP4161567A2 (cg-RX-API-DMAC7.html)
JP (1) JP7888214B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230021115A (cg-RX-API-DMAC7.html)
CN (1) CN116568323A (cg-RX-API-DMAC7.html)
AU (1) AU2021285997A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022024539A2 (cg-RX-API-DMAC7.html)
CA (1) CA3185143A1 (cg-RX-API-DMAC7.html)
MX (1) MX2022015398A (cg-RX-API-DMAC7.html)
WO (1) WO2021248086A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025106427A1 (en) 2023-11-14 2025-05-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Neutralizing and protective monoclonal antibodies against respiratory syncytial virus (rsv)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846455B2 (en) * 1996-07-15 2010-12-07 The United States Of America As Represented By The Department Of Health And Human Services Attenuated chimeric respiratory syncytial virus
US6264957B1 (en) 1995-09-27 2001-07-24 The United States Of America As Represented By The Department Of Health And Human Services Product of infectious respiratory syncytial virus from cloned nucleotide sequences
DE10020505A1 (de) * 2000-04-26 2001-10-31 Conzelmann Karl Klaus RSV NS Proteine antagonisieren die Interferon (IFN) Antwort
BRPI0112276B8 (pt) * 2000-06-23 2021-05-25 The Government Of The Us Secretary Of Department Of Health And Human Services vírus sincicial respiratório (rsv) recombinante infeccioso e polinucleotídeo isolado contendo um genoma ou antigenoma de resv recombinante parcial ou completo
US20080142531A1 (en) 2004-06-25 2008-06-19 Simon Hem Jensen Container Body with an Integrated Handle
PL3511015T3 (pl) * 2012-04-13 2021-09-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Genetycznie stabilna żywa atenuowana szczepionka przeciw syncytialnemu wirusowi oddechowemu i jej wytwarzanie
CA2900713A1 (en) * 2013-02-08 2014-08-14 Steffen Mueller Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
EP3247388B1 (en) 2015-01-20 2025-09-10 The United States of America, as represented by The Secretary, Department of Health and Human Services Recombinant human/bovine parainfluenza virus 3 (b/hpiv3) expressing a chimeric rsv/bpiv3 f protein and uses thereof
WO2017100759A1 (en) * 2015-12-11 2017-06-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Recombinant respiratory syncytial virus strains with mutations in the m2-2 orf providing a range of attenuation phenotypes

Similar Documents

Publication Publication Date Title
US20230021583A1 (en) Measles-vectored covid-19 immunogenic compositions and vaccines
US20240417699A1 (en) Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
Nagai Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding
Durbin et al. Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates
CN100447247C (zh) 重组的感染性不分节段的负链rna病毒
US20230144060A1 (en) MERS-CoV VACCINE
JP5675789B2 (ja) 免疫接種のための発現ベクターとしての水疱性口内炎ウイルスの異なる複数の抗原型
Bailly et al. A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primates
JP2011507514A (ja) Gタンパク質を発現する安定な細胞系を用いた、繁殖欠損水疱性口内炎ウイルスベクターをパッケージングする方法
US11859199B2 (en) Adenoviral vectors with two expression cassettes encoding RSV antigenic proteins or fragments thereof
EP4247420A1 (en) Influenza virus encoding a truncated ns1 protein and a sars-cov receptor binding domain
JP2011507515A (ja) 繁殖欠損水疱性口内炎ウイルスベクターをパッケージングする方法
Peeples Newcastle disease virus replication
CN113430178B (zh) 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用
JP2020522249A5 (cg-RX-API-DMAC7.html)
US12053518B2 (en) Method for rescuing and producing a virus in avian cells
JP2018536428A5 (cg-RX-API-DMAC7.html)
JP2024536236A (ja) 組み換えられた弱毒化rsv生ワクチン及びその製造方法
KR20010080863A (ko) 마진 바이러스 또는 인간 호흡기 합포체 바이러스서브그룹 비에서 감쇠 담당 돌연변이
JP2023529836A (ja) 生弱毒化呼吸器合胞体ウイルス
CN118749028A (zh) 重组减毒rsv活疫苗株及其产生方法